Non-profit life sciences incubator Massachusetts Biomedical Initiatives (MBI) announced that three new companies joined its ...

We speak with a member of BioProcess International's editorial advisory board about the link between friendship and business.

But before we say goodbye to 2025, we leave you with five of our favorite features from this year, delving deeper into a few ...

BPI contributor Justin Byers is cofounder and chief executive officer of Axio BioPharma.

Authors explore complexities in scaling gene-therapy production with special attention is to monitoring and enhancing ...

Cell-line development enhances biopharmaceutical production capacity and quality, but complex biologics like bsAbs and ADCs present new challenges.

A new clinical trial has shown promising safety and efficacy results for liraglutide in the treatment of Alzheimer’s disease.

Biotechnology company Leucid Bio announced a strategic collaboration with Syenex, an open-source gene therapy platform firm.

The company is struggling to make ends meet as it loses a major undisclosed client.

Cell and Gene Therapy (CGT) Catapult, an innovation and technology organization based in the UK, announced the establishment of ReCell. The 13-partner consortium will evaluate how safety tests can be ...

Antimicrobial resistance (AMR) remains one of the most urgent public health threats of our time. By rendering existing antibiotics less effective or even useless, AMR threatens to roll back decades of ...

AI technologies have captured the public imagination and burst into the cultural zeitgeist. Whether through interactive chat programs or AI-generated images, videos, and songs, most of us have ...